Over 150 genes linked to irregular heartbeat condition identified

Image
IANS New York
Last Updated : Aug 05 2018 | 3:55 PM IST

Scientists have used Big Data to identify more than 150 as-yet unknown genetic risk factors for atrial fibrillation, an advance that could potentially improve early detection and treatment.

Atrial fibrillation -- an irregular, often rapid heart rate affecting more than 30 million people worldwide -- increases one's risk for blood clots, stroke, heart failure and death.

For the study, published in Nature Genetics, the team performed one large genome-wide association study (GWAS) comprising data from six smaller studies and identified 151 candidate genes for atrial fibrillation.

Many of the genes identified are important for foetal development of the heart. It implies that genetic variation predisposes the heart to atrial fibrillation during foetal development or that the genetic variation could reactivate genes in the adult heart that normally only function during foetal development.

"We are hopeful that additional molecular biology experiments will determine how to create sustained regular heart rhythms by studying the genes we and others have identified," said Cristen Willer, associate professor at the University of Michigan (U-M).

If atrial fibrillation is detected early, it is possible to prevent complications such as stroke and heart failure. Current treatment options for atrial fibrillation are limited however, include serious side effects, and are rarely curative.

By identifying genes important for atrial fibrillation, researchers constructed a risk score to help identify high-risk individuals and monitor them accordingly, which "may have important implications for precision health and prevention of cardiovascular disease", Willer said.

Of the 151 genes identified as important for atrial fibrillation, 32 are likely to interact with existing drugs not necessarily developed to treat atrial fibrillation.

This study lays the groundwork for follow-up experiments to test whether any of the identified drugs could prevent or terminate atrial fibrillation, the researchers said.

--IANS

rt/ksk/bg

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 05 2018 | 3:46 PM IST

Next Story